0001104659-24-010265.txt : 20240202
0001104659-24-010265.hdr.sgml : 20240202
20240202201017
ACCESSION NUMBER: 0001104659-24-010265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oliviero James F III
CENTRAL INDEX KEY: 0001434718
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 24593589
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
tm245141-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-01
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0001434718
Oliviero James F III
95 SAWYER RD, SUITE 110
WALTHAM
MA
02453
1
1
0
0
CEO, President and Director
0
COMMON STOCK
2024-02-01
4
S
0
11900
2.01
D
369680
D
COMMON STOCK
2024-02-01
4
G
0
12950
0
D
356730
D
In connection with the vesting of 24,850 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.00 to $2.0104. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Includes shares of restricted common stock, which vest over various time periods.
On February 1, 2024, 12,950 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust.
/s/ James F. Oliviero, III
2024-02-02